Implantable measuring device
Abstract
The device includes identical and/or differing sensors for single or continuous determinations. Each produces a signal related to the magnitude measured. A unit converts and transmits the signal. The sensor is implanted close to but outside the relevant blood vessel; a sample feed line reaches into the vessel. Preferred features: Unit overall size does not exceed 400 mu l, preferably 1500 mu l, especially 500 mu l and most especially 300 mu l. Clotting is initiated in the sensor, its course being followed by suitable tracking parameter(s). Numbers of sensors included, determine the same or different parameters. Each sensor is used only once and/or until it fails. The required electrical energy comes from an implantable battery, especially of the open variety; it alternatively arrives through an external transducer. The parameters to be determined react with sensitizer beads, which liberate singlet oxygen proportionately. This is measured by electrodes, converted and transmitted as a signal. The sensor beads are LOCI beads.

Term
Term ended
Projected expiry passed 12 February 2019, 7.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
13 claims: 13 independent, 0 dependent
- 1Diagnostic apparatus for determining analytic parameters, the consisting essentially of:a) a plurality of identical and / or different measurement unit / s (Sensor / s) for one-time or continuous provisions of analytical parameter, wherein each of the measuring units is able to generate a signal to be determined in a specific ratio to the Size / parameter is,i) a signal transmission unit which converts the signal and forwards, andii) a sample feeder to the measurement unit in such a way that the measuring unit is implanted near, but outside of a blood vessel and the A sample loader extends into the relevant blood vessel. Diagnostische Vorrichtung zur Bestimmung von analytischen Parametern, die im wesentlichen besteht aus: a) einer Mehrzahl von identischen und/oder unterschiedlichen Meßeinheit/en (Sensor/en) zur einmaligen oder kontinuierlichen Bestimmungen eines analytischen Parameters, wobei jede der Meßeinheiten in der Lage ist, ein Signal zu erzeugen, das in einem bestimmten Verhältnis zu der zu bestimmenden Größe/Parameter steht, i) einer Signalübertragungseinheit, die das Signal umsetzt und weiterleitet, undii) einer Probenzuführung zur Meßeinheit, dergestalt, daß die Meßeinheit in der Nähe, aber außerhalb eines Blutgefäßes implantiert wird und die Probenzuführung in das betreffende Blutgefäß hineinreicht.
- 2Device according to claim 1, characterized in that it comprises an outer dimension does not exceed 400 ul, more preferably, 1500 .mu.l, particularly preferably 500 .mu.l, particularly preferably 300 ul. Vorrichtung nach Anspruch 1, dadurch gekennzeichnet, daß sie ein Außenmaß von 400 µl nicht überschreitet, bevorzugterweise 1500 µl, besonders bevorzugterweise 500 µl, ganz besonders bevorzugterweise 300 µl.
- 3Device according to one of claims 1 to 2, characterized in that is triggered in the measuring unit of the coagulation process and the course of Coagulation is determined by tracing an appropriate parameter. Vorrichtung nach einem der Ansprüche 1 bis 2, dadurch gekennzeichnet, daß in der Meßeinheit der Gerinnungsvorgang ausgelöst wird und der Verlauf der Gerinnung durch Verfolgung eines geeigneten Parameters bestimmt wird.
- 4Device according to one of claims 1 to 3, characterized in that the device consists of a plurality of measurement units is used to determine of the same parameter are suitable. Vorrichtung nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, daß die Vorrichtung aus einer Mehrzahl von Meßeinheiten besteht, die zur Bestimmung desselben Parameters geeignet sind.
- 5Device according to one of claims 1 to 3, characterized in that the device consists of a plurality of measurement units is used to determine different parameters are suitable. Vorrichtung nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, daß die Vorrichtung aus einer Mehrzahl von Meßeinheiten besteht, die zur Bestimmung unterschiedlicher Parameter geeignet sind.
- 7Device according to one of claims 4 to 5, characterized in that each measuring unit will remain in effect as long as their operability assured is. Vorrichtung nach einem der Ansprüche 4 bis 5, dadurch gekennzeichnet, daß jede Meßeinheit solange verwendet wird, solange ihre Funktionsfähigkeit gewährleistet ist.
- 8Device according to one of claims 4 to 5, characterized in that which is necessary for signal generation and / or transmission power by a mitimplantierte battery, preferably an "open" battery is generated. Vorrichtung nach einem der Ansprüche 4 bis 5, dadurch gekennzeichnet, daß die zur Signalerzeugung und/oder Übertragung notwendige Energie durch eine mitimplantierte Batterie, bevorzugterweise einer "offenen" Batterie erzeugt wird.
- 9Device according to one of claims 4 to 5, characterized in that which is necessary for signal generation and / or transmission of energy through an external transducer is supplied. Vorrichtung nach einem der Ansprüche 4 bis 5, dadurch gekennzeichnet, daß die zur Signalerzeugung und/oder Übertragung notwendige Energie durch einen externen Transducer zugeführt wird.
- 10Device according to claim 3, characterized in that the signal characterized is generated so that the parameter with zubestimmenden Sensitizer Beads react such that the sensitizer beads parameters depending singlet oxygen proposed that measured by suitable electrodes and a transferable Signal is converted. Vorrichtung nach Anspruch 3, dadurch gekennzeichnet, daß das Signal dadurch erzeugt wird, daß die zubestimmenden Parameter mit Sensitizer-Beads derart reagieren, daß die Sensitizer-Beads parameterabhängig Singlet-Sauerstoff abgeben, der von geeigneten Elektroden gemessen und in ein übertragbares Signal umgesetzt wird.
- 11Device according to claim 10, characterized in that the sensitizer beads LOCI -Beads are. Vorrichtung nach Anspruch 10, dadurch gekennzeichnet, daß die Sensitizer-Beads LOCI -beads sind.
- 13Use according to claim 12), wherein the analytical parameter is a coagulation parameters is. Verwendung nach Anspruch 12) wobei der analytische Parameter ein Gerinnungsparameter ist.
Independent claims13
21 paragraphs, as filed
The present invention relates to a diagnostic device for determining analytical parameters that essentially consists of a plurality of identical and / or different units of measurement for the determination of an analytical Parameter in which a signal is generated which in a certain Proportion to the quantity to be determined and which falls through appropriate transfer action to a receiver located outside the body becomes.
An implantable diagnostic devices have been described, for. Example, as Components of implantable insulin pumps. Essentially, there are such Devices of an implantable measuring chamber in which a biosensor an analyte dependent Signal which seinerseit for controlling the insulin pump serves. These devices must be periodically exchanged when the insulin supply is exhausted. Since this exchange is relatively frequently takes place, is the Austauschinterval often shorter than the service life of the biosensors.
A disadvantage of the previous methods, and probably one reason why the previously methods for glucose determination in conjunction with insulin pumps not have been transferred to other parameters, the problem is caused the would if the biosensors over a longer period in contact with blood are and then its function by deposits such. as fat or protein-containing deposits (Clot) impaired or even impossible.
In particular, methods for the determination of coagulation parameters that naturally often accompanied by a clot formation, be as not promising considered.
The object of the present invention is based was to provide a diagnostic to provide apparatus which enables the intervals between the Replacing the devices to significantly increase.
Surprisingly, it was found that the device according to the invention containing both Einzelmeßkammer, and in a multiple measuring chamber Apparatus advantageously used for the determination of coagulation parameters can be.
The device according to the invention thus consists of one or more measuring chambers, in turn, consists essentially of three parts, namely the actual Measurement chamber, a fact excellent cannula, in turn, into a vessel are projects, detected in the liquid volume of analytical parameters should. Further, associated with each measuring chamber - or even at all measuring chambers together - a signal transmission unit. The tube-side end of the cannula can advantageously be completed by a filter through the but the analytes allows cells restrains. The cannulas are further provided with a flap provided that operated by the action of an extracorporeal signal can be.
The diagnostic device is advantageously additionally provided with a device provided for storing the measuring signals, which are then retrieved as needed can.
A preferred embodiment of the measuring chamber is shown in figure 2.
Advantageously, a plurality of measuring chambers is a diagnostic Device combined with the number of Einzelmeßkammern preferably Is 20 to 50. The number as such is not critical, it is based on a Determining a week, so a number of 50 ± 10 appears particularly advantageous, since in this case an exchange per year is sufficient.
The method and apparatus according to the invention can be used both for flow measurements as be equipped for single determinations. By the possibility of contactless signal transmission may advantageously both stationary as well as outpatients without an additional restriction of movement the patients are used. The types of signal transmission are the Skilled known. The structure of an embodiment of the device is in 1 shown FIG.. The structure of a special measuring chamber is shown in Fig. 2A. The preparation is sufficiently smaller measuring chambers with at the skilled worker known methods possible.
Of particular importance is the closure of the measuring chambers. Here can advantageously magnetically operable shutters, take the 2 solid states can (flip-flops) are used. In FIG. 2, B is an arrangement of several measuring chambers shown. The light supply to the individual measuring chambers can separately as either correspondingly small, for each measurement chamber arranged light sources such as light emitting diodes, or via corresponding light guides done.
Advantageously, each measuring chamber the one or more necessary for the reaction Reagent (s), eg thromboplastin for a PT (thromboplastin time, "Prothrombin time) determination. With the usual in the coagulation applied Determination method is the innovative technology difficult to realize. Advantageously, a new technology is applied, in the following will be described.
Thus, for. Example, singlet oxygen emitting particles (SSEP), the z. B. are EP 0515194 describes used. This SSEPs be in the applied measurement chamber on a conductive surface, for example made of carbon together with the analyte-specific reagents. In the measuring chamber extends a Light source that irradiates a light, which is suitable to excite the SSEPs. If clotting occurs, the mobility of SSEPs is changed, usually restricted, thereby to SSEPs accumulate the conductive surface and it produces a measurable current flow (see also Fig. 3).
An analogous method can be applied for immunological determinations, wherein a specific binding partner immobilized on the conductive surface , and by the analyte SSEPs, also specific with one, for the analyte Binding partners are coated, bonded in the vicinity of the conductive surface , which in turn to a measurable change in the current flow leads.
An advantageous embodiment can be carried out as follows:
A device consisting of the elements of a measuring unit, a signal-processing Unit and a cannula is implanted under the skin so that the Cannula projects into a vessel. The units are by means of Micro technology as For example, in the manufacture of integrated circuits (chip technology) uses are produced and characterized so small that they known endoscopic techniques can be implanted. For testing, a launched external receiver and the power to measure transmitted conductively. Simultaneously, the measurement signals or results are transmitted to the receiver and can be called up there.
The measuring unit consists of discrete measuring chambers which individually closed by valves can be and can be used only once, and a Pumping device in connection to the cannula, and, if applicable. To a reservoir with physiological NaCl to flush the cannula. Further contains the measuring unit a light generator, such as a microlaser, and power lines for the disposal and Processing of the measurement signal. The measuring chamber contains a miniaturized diode is connected via an optical waveguide with the central light generator. In the Measuring chamber are used to detect the plasma protein or the Coagulation Analysis necessary reagents. The process for preparing the discrete components, such. as valves or pumps are known to those skilled in the known.
Detection of the reaction is carried out via a novel combination of sensitizer beads from the LOCI technology with an amperometric sensitive circuit board. By excitation with light of oxygen free radicals are generated, which on the printed circuit board produce a measurable signal. When a clot this arises immobilization preferably near the circuit board. The free solution can be held by a stirrer in motion. For immunochemical reactions are immobilized on the Obertläche corresponding binding partner. By Binding of the sensitizer beads to the analyte to be detected, which to the binding partner the surface is bonded, the sensitizer beads in the be brought close to the circuit board, so that more likely a transmission of charge (oxygen radicals) occurs. The measuring signal is thus the concentration of analyte proportional. Alternatively, the common reagents LOCI system consisting of Sensitizer and acceptor beads are used. In the measuring chamber is located then a light receiver in place of the circuit boards.
The signal verbeitende unit includes an arithmetic processor and a transducer for transmission of results, and other electrical units for energy reception.
The cannula may contain filters that the exclusion of cellular components ensure the blood so that plasma is used for analysis. through rear Rinse with saline can by measurement Access channels, cannula and filters are cleaned.
5 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP1358460A2 | Cited by | European Patent Office (EPO) | Search report |
| AU2002225316B2 | Cited by | Australia | Search report |
| KR100893519B1 | Cited by | Republic of Korea | Search report |
| EP1358460A4 | Cited by | European Patent Office (EPO) | Search report |
| US7468044B2 | Cited by | United States of America | Applicant |
| US7901366B2 | Cited by | United States of America | Applicant |
| DE3933373A1 | Cites | Germany | Search report |
| US5711861A | Cites | United States of America | Search report |
| US5833603A | Cites | United States of America | Search report |
11 members in 8 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 19811017 | Germany | A | |
| 19811017 | Germany | A | |
| 19811017 | Germany | – | |
| 19811017 | – | – | – |
| DE1998111017 | – | – | – |
Members11
| Document | Office | Kind | |
|---|---|---|---|
| CA2264333A1 | Canada | A1 | |
| DE19811017A1 | Germany | A1 | |
| AU2039199A | Australia | A | |
| EP0945102A2This record | European Patent Office (EPO) | A2 | |
| JPH11318873A | Japan | A | |
| EP0945102A3 | European Patent Office (EPO) | A3 | |
| US6198950B1 | United States of America | B1 | |
| EP0945102B1 | European Patent Office (EPO) | B1 | |
| AT327713T | Austria | T | |
| DE59913476D1 | Germany | D1 | |
| ES2262261T3 | Spain | T3 |
50 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Change of name or company nameCD | CD | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: ep patent (uk) treated as always having been void in accordance with gb section 77(7)/1977 [no translation filed]GBV | GBV | EP | |
| Fr: translation filedET | ET | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| European patent grantedGrantedNOT ENGLISHFG4D | FG4D | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Title (correction)IMPLANTABLE MEASURING DEVICERTI1 | RTI1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designation fees paidAT BE CH DE ES FR GB IT LI LU NL SEAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0945102
- Publication, DOCDB
- 0945102
- Publication, EPODOC
- EP0945102
- Application
- 99102671
- Application, DOCDB
- 99102671
- Application, EPODOC
- EP19990102671
Titles3
- German
- Neues Verfahren zur Bestimmung von Plasmaproteinen und Faktoren der Hämostase sowie ein neues, implantierbares Messgerät
- English
- New procedure for determination of plasmatic proteines and homostase factors and new implantable measuring device
- French
- Nouveaux procédé pour la détermination des protéines plasmatiques et des facteurs de la hemostase et nouveaux dispositif de mesure implantable
Classification
- CPC, 6
- A61B5/1459
- A61B5/14532
- A61B5/1495
- A61B5/6848
- G01N33/86
- Y10S128/903
- IPC, 4
- A61B5 145
- A61B5 00
- A61B5 1473
- G01N33 86
Designated states25
- Contracting states, 19
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Extension states, 6
- Albania
- Lithuania
- Latvia
- North Macedonia
- Romania
- Slovenia